Goldenwell Biotech, Inc.

OTCPK:GWLL Stock Report

Market Cap: US$19.8m

Goldenwell Biotech Management

Management criteria checks 2/4

Goldenwell Biotech's CEO is Shuang Liu, appointed in Aug 2019, has a tenure of 5.08 years. directly owns 41.41% of the company’s shares, worth $8.20M. The average tenure of the management team and the board of directors is 5.1 years and 5.1 years respectively.

Key information

Shuang Liu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.1yrs
CEO ownership41.4%
Management average tenure5.1yrs
Board average tenure5.1yrs

Recent management updates

No updates

Recent updates


CEO

Shuang Liu (60 yo)

5.1yrs

Tenure

Mr. Shuang Liu is President, Chief Executive Officer and Director at Goldenwell Biotech, Inc. since August 20, 2019 and is its Chairman. Since December 2012, Mr. Liu is our principal accounting officer and...


Leadership Team

NamePositionTenureCompensationOwnership
Shuang Liu
Chairman5.1yrsno data41.41%
$ 8.2m
Hua Xie
Secretary5.1yrsno data5.05%
$ 1.0m
Li Yang
Treasurer & Director5.1yrsno data10.1%
$ 2.0m

5.1yrs

Average Tenure

55yo

Average Age

Experienced Management: GWLL's management team is seasoned and experienced (5.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shuang Liu
Chairman5.1yrsno data41.41%
$ 8.2m
Hua Xie
Secretary5.1yrsno data5.05%
$ 1.0m
Li Yang
Treasurer & Director5.1yrsno data10.1%
$ 2.0m

5.1yrs

Average Tenure

55yo

Average Age

Experienced Board: GWLL's board of directors are considered experienced (5.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/24 23:44
End of Day Share Price 2024/06/28 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Goldenwell Biotech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution